Open access peer-reviewed chapter

Alginate-Based Composite and Its Biomedical Applications

Written By

Yaling Deng, Ningning Yang, Oseweuba Valentine Okoro, Amin Shavandi and Lei Nie

Submitted: July 15th, 2021 Reviewed: July 16th, 2021 Published: August 12th, 2021

DOI: 10.5772/intechopen.99494

Chapter metrics overview

214 Chapter Downloads

View Full Metrics


Alginate has received much attention due to its biocompatibility. However, the properties of pure alginate are limited, such as weak mechanical strength, which limits its application. Alginate-based composite effectively overcomes the defect of pure alginate. The molecular weight and microstructure can be designed. More importantly, the essential properties for clinical application are improved, including mechanical properties, biocompatibility, gelation ability, chondrogenic differentiation and cell proliferation. This chapter will describe development of alginate-based composite in biomedical application. In the fields of wound dressing, drug delivery, and tissue engineering, the impact of structural changes on performance has been stated. To provide readers with understanding of this chapter, the structure and characterization of alginate will be included.


  • Alginate
  • composite
  • wound dressing
  • drug delivery
  • tissue engineering

1. Introduction

Alginate is a natural heteropolysaccharide extracted from brown seaweed. Due to the abundantly available in nature and less expensive, L. hyperborea, L. digitata, Laminaria japonica, A. nodosum, and M. pyriferaare the main choice of alginate [1]. Alginate, without pungent smell, usually has a white or yellowish-brown character. It is water-soluble but insoluble in organic solvents, such as alcohol, chloroform. Carboxylic acid groups in the saccharide residue endow the special anionic nature. Calcium alginate, for instance, is insoluble, while sodium alginate has water-solution [2]. However, the process of water dissolving is slow and usually takes several hours, forming stable and viscous solutions [3]. Due to the ability to form a hydrogel, alginate could be utilized as a gelling agent, which expands its application in the field of biomedical applications.

Alginate and its derivatives show outstanding properties, such as biocompatibility, biodegradation, gel-forming ability, being suitable for sterilization and storage. Owing to its unique characteristics, alginate has been widely used in diverse fields, including wound dressings, drug delivery, tissue regeneration. In this chapter, the characteristics and wide applications of alginate will be introduced.


2. Structure and characterization

2.1 Structure

Alginate with molecular weight between 32,000 to 400,000 g/mol is mainly comprised of a sequence of liner polymers of β-(1–4)-D-mannuronic (M-blocks), α-L-guluronic acid (G-blocks), and inserted MG sequences (MG-blocks), with varying proportions and linear arrangements [4]. That organized in homogenous patterns with repeated G residues, repeated M residues, and heterogenous patterns with alternating G and M residues [5]. Alginate derived from different sources displays different M/G ratios and contents in M and G [6], leading to the change of molecule weight and physicochemical properties. These parameters are related to the characteristics and applications of alginate. Generally, alginate with high M units shows good biocompatibility and more immunogenic [7]. Alginate with high M units has soft and elastic properties, G-rich alginate exhibits hard and brittle characteristics [8, 9]. The rigidity of the chains increases in a sequence, MG < MM < GG, due to the electrostatic repulsion between charged groups. G-rich alginate gels have better mechanical stability (Figure 1) [5].

Figure 1.

Chemical structure of alginate [5].

The electrostatic interactions between the carboxylate groups of G units and divalent cations, such as Ca2+, Fe2+, Mg2+, form an “egg-box” structure, which crosslinks to obtain the hydrogels. There are several hydroxy and carboxyl groups in the molecular structure of alginate. As the active site, more groups and side-chain molecules were introduced into the main chain to decorate the structure, which endow more features and expand its applications [10].

2.2 Solubility and viscosity

Sodium alginate exhibits slowly water-soluble and forms viscous and stable solution. At low solvent pH, more heterogeneous MG-blocks contribute to solute than M-rich and G-rich alginate [11]. With the decrease of pH, the viscosity of alginate solution increase. When the range of pH is 3–3.5, the viscosity has the maximum. In the Mark-Houwink relationship ([η] = KMva), [η] is intrinsic viscosity (mL/g) and Mvis the viscosity-average molecular weight (g/mol)[12]. For sodium alginate in 0.1 M NaCl solution at 25°C, K and a, the parameter of the Mark-Houwink relationship ([η] = KWva), are 2 × 10−3, a = 0.97 respectively.

The primary structure is associated with different amounts and sequential distribution of M and G, which affects the molecular weight and properties. For example, the viscous behavior is remarkably relevant to molecular weight during the preparation. Alginate with high molecular weight polymer could form an obviously viscous solution [13] and result in a higher elastic modulus in the gels [14]. Meanwhile, the alginate with a long chain shows a higher solution viscosity. For example, G-rich alginate displays more excellent water solubility than M-rich alginate [15].

2.3 Biocompatibility

Alginate has excellent biocompatibility, that has been widely assessed. However, some gaps of biocompatibility between alginate and alginate complex still exist. For purified alginate gels, the relative amounts and distribution of M and G have an effect on biocompatibility [16]. For example, M. Otterlei et al. reported that alginates with low G were approximately 10 times more potent inducing cytokine production compared with high G alginates [7]. S.K. Tam et al. found that gel beads prepared with alginate contenting intermediate guluronate (IntG, 44% G) exhibited better biocompatible than high guluronate content (HiG, 71% G). There are no inflammatory reactions around alginate implants [17]. For the alginate complex, the impurities from alginate-based materials, such as heavy metals, proteins, and polyphenolic compounds, have the potential to cause an immunogenic response. A multi-step extraction procedure reduces the concentration of impurities and will not cause foreign body reactions. Meanwhile, the biocompatibility properties of alginate are attributed to hydrophilicity, chain migration, and water-absorbing [18]. Swelling properties contribute to enhance biocompatibility, that limiting the adsorption of proteins and cells of immune response [19].

2.4 Degradation

Degradability of biomaterials, as a critical property, contributes to providing a biomimetic microenvironment for use in cell delivery, survival, and expansion [20]. Hydrolytic is the main reason for degradation, which will be initiated spontaneously after contacting water-based fluids [21]. The degradation rate is related to the molecular weight of alginate. Generally, with the increase of molecular weight, the amounts of reactive sites for hydrolysis degradation decrease, that reduce the degradation rate [22]. Degradation, accompanied by adjusting the structure and molecular weight distribution, has an effect on the mechanical properties. In the physiological environment, alginate will undergo rapid degradation [23]. For alginate hydrogel, the degradation process will be accomplished by releasing the divalent ions into the surrounding environment. However, some residues of alginate still exist and will not be removed [24]. Many physical and chemical methods have been used to control alginate degradation, including ultrasonic, ultraviolent, gamma irradiation, and partial oxidation.


3. Applications

The various physicochemical properties of alginate are favorable to extensive usages, such as the ability to form a gel and the ability to maintain a moist environment, which has been confirmed by the literature. Due to the biocompatibility and nontoxic, alginate has been applied in biomedical applications, such as wound dressing, drug delivery, and tissue engineering.

3.1 Wound dressing

Skin, as the largest human organ, plays a vital role in protecting the human body from outside germs [25]. It is also a vulnerable organ. Once the skin is damaged, all kinds of microbes and pathogens will gather around the wound site to affect the wound closure cause bacterial infection. For severe wounds with large, deep, or bleeding, handling and management are essential [26]. Wound healing is a complex process, involving the treatment of infectious, germs. Therefore, wound dressing has been attracted extensive attention and is widely used to accelerate wounding recovery and to control infection. Traditional dressing, consisting of sterile pad and gauze, has the features of preventing the invasion of germ into the wound site and keeping dry [27]. Some disadvantages of these dressings are displayed during the application, such as poor vapor transmission, susceptiblity to bacterial infection, and easy adhesion, which seriously interfere with wound healing. With the rapid development of technology, some biomaterials such as polysaccharides, proteoglycans, and proteins have been investigated for wound healing owing to their ability to accelerate healing and control infection [28, 29]. These polymers have been utilized to develop modern dressing due to its high water-content, biodegradable, and biocompatibility. Therefore, modern wound dressing effectively mimics the features of natural tissue and offers a moist environment, better water vapor permeation, autolytic debridement, which cause to promote re-epithelialization and accelerate wound healing [30].

Alginate, as one of these biomaterials, has been widely concentrated and investigated because of its biocompatibility and water-retaining capacity [31]. It has the ability to carry pro-inflammatory signals and initiate or accelerate the healing of chronic wounds [32]. Currently, there are several forms of alginate dressing on the market, including hydrogel, films, membrane, and sponges. Ionic cross-linking is a representative fabrication method of alginate dressings. Multivalent ions are chosen to fabricate gel, such as calcium [33], magnesium [34], iron [35]. Free-dried porous sheets and fibrous dressing that followed are formed. Alginate dressings are characterized by absorbing wound fluid, physiologically moist environment, maintain the optimal pH, and reduced bacterial infections, that improve the physicochemical stability [36, 37].

Alginate wound dressings with multifunctional properties have been investigated for nearly 40 years. Kaltostat® alginate dressing, as a famous wound dressing, has been designed and applied to absorb exudate and avoid infections, especially calcium sodium alginate dressing. Nevertheless, only 70% wound closure is exhibited [38]. Considering that single alginate dressing could not completely prevent infections and moderate wound healing, the development of effective alginate dressing, based on biopolymers and nanoparticles, draw much attention and expanded research.

Alginate composites combining natural polymer and synthetic polymer are utilized to prepare dressing hydrogel via physical or chemical methods. Chitosan, as a typical natural polymer, has several advantages, such as biocompatibility, biodegradability, ionic character, and hemostatic properties. It could be incorporated with alginate to create bioactive interpolymer (polyelectrolyte) complexes and promising wound dressing. Wound dressing formed with this method exhibited superior water uptake of 4343.4% over 24 h and 78% biodegradation than commercial Pharma-Algi wound dressing [39]. Mudlovu et al. fabricated an alginate-chitosan bioplatform through a three-step method; partial-crosslinking of polymers, lyophilization, and pulverization (Figure 2) [39]. These wound dressings showed a higher degree and rate of fluid uptake (3306.61%, 4343.4%) than Pharma-Algi® (2168.21%; 1612.56%). For chitosan with high (MW ~ 800 000) and low (MW ~ 3000) molecular weight, it was mixture as a coating to develop calcium alginate dressing. The results showed that chitosan promotes angiogenesis by increasing VEGF and exhibits better wound healing than pure calcium alginate dressing [40]. In addition to the natural polymer, poly (vinyl alcohol) (PVA), as a type of common synthetic polymer, has the inherent characteristics of non-toxic, non-carcinogenic, biocompatibility. PVA hydrogel formed with cross-linking method has desirable properties such as high swelling rate, keeping the moist environment. Therefore, PVA has been attracted attention and explored for wound dressing. PVA-alginate hydrogel enhanced swelling properties and protein adsorption. When alginate has a high ratio in the PVA/Calcium alginate wound dressing, high a water vapor transmission rate, 2725.8 g/m2/2h, was obtained, which contributes to holding a moist environment [41].

Figure 2.

(A) Schematic representation of the three-step method of partial-crosslinking and interpolymer complexation of the polymers. (B) (a) biodegradation and (b) water uptake behavior of the pristine polymers, bioplatforms and pharma-Algi® in PBS (pH 7.4) solution at 37°C at 50 rpm [39].

In order to endow the additional effects and accelerate wound healing, the antimicrobial agent has been incorporated into the wound dressing. Silver nanoparticles (AgNPs), as a promising wide-spread local antibacterial agent, have demonstrated huge potential and received more attention in the area of microbial resistance. Wound dressing carried with AgNPs is considered to control and treat acute and chronic wounds, accompanied by rapid healing via accelerating reepithelialization [42]. Alginate dressings incorporated with silver have highly absorbent features of alginate and antimicrobial efficacy of silver. Silver-loaded hydrogel has a uniform pore structure, had excellent water absorption and water retention, maintaining a moist wound environment for wounds [43]. The antibacterial performance is also improved. Alginate/carboxymethyl cellulose silver dressing was found to have a sustained antimicrobial effect against microorganisms, for up to 21 days [44]. The sustain and stable release of sliver minimize clinical treatment time and relieve the patient’s pain. Compared with pure alginate, alginate dressings incorporating ionic silver and nanocrystalline silver were confirmed to enhanced antimicrobial effect, improved the binding for elastase, matrix metalloproteases-2, and proinflammatory cytokines, and boosted the antioxidant capacity [45].

3.2 Drug delivery

Drug delivery systems could transport and release drug molecules to a target position under the microenvironment, especially for poorly water-soluble drug molecules. Many polymers have been explored and investigated for drug delivery. Due to the outstanding biocompatibility and gelation properties, alginate has been received wide attraction and utilized in drug delivery applications. Alginate could be prepared excipient. Three forms of participation are exhibited, such as solid dosage, semisolid dosage, liquid dosage. Solid dosage form contains tablets and capsules, while, gels and buccal patches are the most common semisolid dosage. Liquid dosage usually includes emulsions and suspensions. Alginate could be decorated to adjust the properties for novel drug release. Due to the facility to bond with drug molecules and rapid gelation in a mild environment, alginate could be utilized to modulate the drug release properties. D.J. Mooney et al. found that the pore size of alginate gel is about 5–6 nm [46], which contributes to the diffusion and release of drug molecules.

Alginate could be utilized to design microcapsules for sustained release of the drug, which has attracted extraordinary attention by the reason of outstanding advantages, including high drug loading rate, satisfactory biodegradable, non-immunogenic, and non-toxicity. Stimuli-responsive alginate-based microcapsules had shown a potential for targeted delivery and release drugs. Drug delivery system using magnetic nanoparticles was reported. Magnetic nanoparticles have the ability to control movement and aggregation at the target sites during the process of the external magnetic field. Therefore, the system could obtain a high local concentration at the target sites. It is demonstrated that magnetic reduction-responsive alginate-based microcapsules (MRAMCs) systems exhibited good magnetic targeted ability owing to the superparamagnetism of OA-Fe3O4 nanoparticles [47]. In addition, alginate microcapsules encapsulated glucocorticoid is a novel method for the treatment of osteoarthritis. E. Lengertet al. found that hollow silver alginate microcapsules could effectively deliver water-insoluble glucocorticoid betamethasone [48]. This system enhanced loading efficiency and sustained release, reducing the injury rate of intraarticular glucocorticoids delivery.

Alginate, as a well-known drug carrier, is utilized to prepare wound dressing. Antimicrobial agents or drugs are encapsulated into the hydrogel. Wound dressing provides a moist environment, and more importantly, drugs release to the wound and facilitate the healing. For example, alginate-based dressing encapsulated with vancomycin has a 44% drug release rate after 24 h, and the antimicrobial activity against various bacteria was confirmed [49]. Recently, double-membrane hydrogel formed with alginate and cellulose nanocrystals was developed. The results showed good release behaviors for complexing antibiotic drugs. The rapid drug release was completed by outer neat alginate hydrogel, meanwhile, the prolonged-release behavior corresponded to the inner hydrogel [50]. Another dual-drug delivery system, poly (D, L-lactic) (PDLLA) microspheres embedded in calcium alginate hydrogel beads, was developed by D.G. Zhong et al. [51]. The microspheres encapsulated glycyrrhetinic acid showed a sustained release, and hydrogel loaded with BSA exhibited a rapid release.

pH-sensitive alginate carrier was investigated to enhance the efficacy, especially for localized drug delivery systems. The pH-sensitive reversible bond can control the drug delivery. C. H. Park and C. S. Kim prepared AlgPD-BTZ hydrogel using alginate-conjugated polydopamine as a building block polymer (Figure 3) [52]. The catechol group binds to the boronic acid group of BTZ drug, that covalent bond is a pH-sensitive reversible bond. Therefore, the system showed that BTZ was selectively released in cancer cells with a pH-dependent method. Sodium alginate could be used as a pH-sensitive bilayer coating on iron oxide nanoparticles by combining hydroxyapatite to deliver drug molecules. The higher encapsulation efficiency was detected, 93.03 ± 0.23% for curcumin and 98.78 ± 0.05% for 6-gingerol [53]. The electrostatic interactions of molecules could act as an adjustable gate to hold and release the drug molecules depending on the pH. The pH triggered drug-releasing mechanism play a virtual role in the releasing of tumor drug owing to the leaky vasculature [54].

Figure 3.

The synthesis of AlgPD-BTZ hydrogel and drug release properties. (a) Schematic of the synthesis process of AlgPD-BTZ hydrogel by the conjugation of dopamine to the alginate backbone, and subsequent oxidation of catechol groups for cross-linking; (b) pH sensitive cumulative drug release from AlgPD-BTZ hydrogel; (c) scheme shows pH sensitive boronic ester bond of BTZ with the polymeric catechol group and the drug release mechanism [52].

In addition, alginate hydrogels are an excellent candidate and have been studied for protein drug delivery. Protein incorporated into hydrogels is protected, which reduces the denaturation and avoids degradation. Alginate hydrogels containing adjusting factors of neovascularization, vascular endothelial growth factor (VEGF), exhibited a sustained release, within 7 days approximately 60% of the total VEGF [55]. The protein release rate can be controlled by altering the degradation rate of alginate hydrogel. Also, sodium alginate-bacterial cellulose hydrogels had shown promising potential for carrying protein-based drugs, lysozyme (LYZ), via electrostatic adsorption [56].

3.3 Tissue engineering

Tissue engineering, proposed by National Science Foundation in 1987, belongs to the field of biomedical engineering, which is a valuable approach and can be used to restore, maintain, enhance tissues and organs [57]. Tissue engineering involves the getting of seed cells, biological scaffold materials, preparation of tissue and organs, and its clinical application. The biological scaffold materials were utilized to encapsulate and support the propagation of cells. Afterward, these materials were transferred into the body and the target tissues were eventually formed. The research principal field contains bone [58], cartilage [59], vascular [60], ocular tissues [61], skin [62], and other tissues [63].

Alginate, as a most commonly known biomaterial with outstanding properties of scaffold-forming, has been extensively investigated and developed to treat the loss or failure of organs in tissue engineering. It usually combines with other substances to form new alginate derivative materials with the methods of physical or chemical. The different features and functions are obtained, accompanied by improved properties for tissue engineering, such as mechanical strength, cell affinity, and gel-forming ability. Therefore, alginate and its composite have received much attention in tissue engineering.

3.3.1 Bone

Bone has the hierarchical structure forming with 70% of nano-hydroxyapatite (HA, Ca10(PO4)6(OH2)) and 30% of collagen by weight [64]. It is a rigid connective organ and plays a major role in the movement of organs, involving affording structural framework, mechanical support and protection, mineral storage, and homeostasis [65]. There are several ways to cause bone defects or fractures in daily life, involving sports injury, accident damage, osteoporosis, osteoarthritis, bone neoplasm, and so on. Bone tissue engineering, as an effective alternative treatment for restoring bone defects, has addressed much attention. Several therapies have been available to treat bone defects or loss, including autograft (bone from patient’s own healthy tissue), allograft (bone from the human donor), and xenograft (from other species) [66]. The final goal of bone tissue engineering is to construct bone tissue that should have the same qualities of structurally, physical, and chemical features as natural bone tissue. Alginate has been extensively investigated to synthetic scaffolding materials for bone reconstruction and transfer cells for bone tissue engineering [67].

Sufficient mechanical strength of scaffold in bone tissue engineering is essential to support bone regeneration. To obtain enough mechanical properties, alginate composite scaffolds were prepared mixing other polymers or inorganic components, such as chitosan, collagen, and hydroxyapatite. Chitosan, as a most abundant cationic polysaccharide, is selected to form alginate-chitosan composites. Chitosan/alginate composite scaffolds are extensively investigated for bone tissue engineering. The rigid strength and structural stability are obtained. S. J. Florczyk et al. prepared a chitosan-alginate scaffold with enhanced compressive strength, 0.79 ~ 1.41 MPa [68]. It has the homogeneous pore structure, and the pore size depends on acetic acid and alginate concentration (Figure 4). The cell proliferation potential was also improved when the viscosity was below 300 Pas. The greatest defect closure (71.56 ± 19.74%) was observed at 16 weeks [69]. Chitosan/alginate scaffolds present advantages in stimulating osteogenesis and vascularization [70]. Collagen is usually utilized to prepare scaffolds because of its specific properties, such as inducing cell adhesion and degradation [71]. Collagen I, as the essential component of bone tissue’s ECM, contributes to migrant and penetration of osteoblasts and vessels [71, 72]. Therefore collagen/alginate hybrid scaffolds have an effect on the osteogenic ability of osteoblasts. It could promote cell spreading, proliferation, and osteogenic differentiation. S. Sotome et al. demonstrated that hydroxyapatite/collagen-alginate could deliver recombinant human bone morphogenetic protein 2 (rh-BMP2) efficiently [73]. There is bone formation within 5 weeks after implantation, accompanied with no obvious deformation. Hydroxyapatite (HA) is the main component of bone. The structure of alginate combined HA composites is similar to the native extracellular matrix of bone. The interconnected porous structures and high porosity promote good cell viability, proliferation rate, adhesion, maintenance of osteoblastic phenotype, and bone regeneration [74]. The results of Lin et al. showed that alginate/HA is the better composite porous scaffold with an average pore size of 150 μm and over 82% porosity [75]. In another report, the alginate/HA composite scaffolds have 84% porosity [76]. The uniform pore morphology is favorable to improve compressive strength and elastic modulus, which is proportional to the content of HA. The satisfactory scaffold should have excellent performance to promote bone tissue growth, such as mechanical strength, cell proliferation, and morphology [77]. N. Firouzi et al. found that the addition of HA in alginate-based hydrogel could reduce degradation rate to 41.5%, and significantly improve compressive modulus, reaching 294 ± 2.5 kPa [78]. Meanwhile, microencapsulated osteoblast-like cells showed more proliferation as well as metabolic activities when they were cultured in Alg-Gel Ph-nHA microcapsules during the culture period.

Figure 4.

(A) SEM images of CA PEC scaffold pore structures made from CA solutions (4 wt % chitosan and 3.75 wt % alginate) with acetic acid concentrations of (a) 0.75 wt %, (b) 1.0 wt %, (c) 1.25 wt %, (d) 1.5 wt %, (e) 1.75 wt %, and (f) 2.0 wt %. The arrows indicate incomplete interconnects and scale bars are 100 μm. (B) Compressive Young’s moduli of CA PEC scaffolds prepared from CA solutions (4 wt % chitosan and 3.75 wt % alginate) with varying acetic acid concentrations. *the significant differences between the scaffold groups for the modulus measurements. (C) Influence of mixing temperature on viscosity of CA PEC solution (1.0 wt % acetic acid, 4 wt % chitosan, and 3.75 wt % alginate) at zero shear rate [68].

3.3.2 Cartilage

The articular cartilage is an organized and specialized tissue that is highly hydrated (up to 80%), aneural, devoid of blood or lymphatic vessels [79]. It is the connective tissue covering the surface of articulating bones, that provides the lubrication and mechanical strength for body weight and movement. Other body organs are also made by cartilage, such as the ear, nose, bronchial tubes, and so on. Cartilage has a restricted self-repair and regenerative capacity because of lacking nerves and blood vessels. It cannot heal appropriately after the injury, which eventually causes osteoarthritis and cartilage damage. Therefore, repair or reconstruction of damaged cartilage is still a major challenge. Tissue engineering is the potential approach to solve damaged or degraded cartilage. It could mimic the structure and function of body cartilage tissue, stimulating cartilage growth and restoration at the damaged sites. The tissue engineering scaffold has the three-dimensional structure for cell attachment/proliferation.

Alginate scaffolds have been proved to apply for the regeneration of cartilage tissue. It can induce redifferentiation of 2D culture-expanded dedifferentiated chondrocytes [80], therefore alginate could promote the growth of chondrocytes cells, restore damaged cartilage, and keep chondrocyte properties [81]. Chitosan-alginate scaffold effectively promotes the culture of osteogenic and chondrogenic cells. A.E. Erickson et reported that alginate-chitosan + hydroxyapatite scaffolds displayed a defined, interconnected porous network structure [82]. The compressive modulus and stiffness increased with polymer content. After culturing with chondrocyte-like (mesenchymal stem cells, MSC), the number of cells on 4% CHA scaffolds was significantly higher than the number of MSCs on 6% CHA scaffolds at day 10 (Figure 5) [80]. Hyaluronate, in addition, was explored to reinforce alginate to improve chondrocyte proliferation. It is demonstrated that alginate-hyaluronic acid hydrogel has stable physicochemical properties. C. Mahapatra et reported that alginate-hyaluronic acid-collagen hydrogel provided a binding motif for chondrocytes [83]. These gels effectively protected chondrogenic phenotypes after three weeks of cultivation. The results demonstrated the efficient expression of chondrogenic genes and the formation of cartilage ECMs. Another alginate hybrid gel made combining with polyacrylamide was confirmed to have remarkable mechanical strength, such as high toughness (up to 9000 J/m2) and stretch ratio [84, 85]. It has also been proved that alginate-polyacrylamide showed good tribological behavior, ultra-low coefficient, and high wear-resistance [86]. After transplantation, chondrocytes displayed an organized distribution and superior integration with surrounding tissue (Figure 6) [87]. Alginate and its composites provide chondrogenic differentiation and cell proliferation, therefore, these hybrid gels can be used as cartilage implants.

Figure 5.

Effect of HAp concentration on 6% CA scaffold properties. a, b visualization of HAp nanorods with TEM. Scale bars represent 200 nm, and 100 nm, respectively, in (a) and (b). c SEM images of scaffold pore morphology with varying HAp (HAp concentration increases from left to right). Scale bar represents 200 μm. d density of CA + HAp composite scaffolds (n = 8) (p ≤ 0.05). (e) MG63 proliferation on CA + HAp composite scaffolds over a 2-week culture period (n = 4). *statistically significant from all or specified conditions (p ≤ 0.05). **statistically significant from all conditions except 0.1% HAp (p ≤ 0.05) [80].

Figure 6.

In vivorepresentative photomicrographs of tissue sections in the experimental groups stained with (A, B, C) H&E; (D, E, F) safranin O/fast green, (G, H, I) Gomori’s trichrome stains, TB (J, K,L), and PAS (M, N,O). (A, D, G) control group demonstrates mostly fibrous tissue with limited tissue repair in the chondral region. (B, E, H) PAAm-Alg group shows fibrous tissue with few fibroblast and chondrocyte-like cells in the joint surface chondral regions. (E) Fibrous tissue in the deeper regions is still observed in some rats. (C, F, I) PAAm-Alg-NPTGF-β3 group reveals fibrous tissue with some fibrocartilage and hyaline cartilage groups in the chondral regions. PAAm-Alg and PAAm-Alg-NPTGF-β3 groups demonstrated higher (K, L) glycosaminoglycan deposition and (N, O) glycoprotein and proteoglycan contents compared to control group (the arrows indicate the margins of the defect area; scale bars: 100 μm) [87].

3.3.3 Liver tissue engineering

Liver disease is a great threat to human health, and it is one of the major reasons for the increased mortality. There are about 2 million deaths all over the world every year [88]. Liver transplantation is the most effective way to solve this problem. Yet, this is a very difficult process because of lacking suitable liver donors. Liver tissue engineering is considered the best way to provide liver to meet the excessive requirement of the liver. It could improve the function of the liver and form a complete organ.

Alginate composites can be used for hepatocyte growth in liver tissue engineering. For example, R. Rajalekshmi et al. reported that fibrin (FIB) incorporated injectable alginate dialdehyde (ADA) - gelatin (G) hydrogel effectively supports growth, proliferation, and functions of hepatic cells [89]. The reason is that fibrin provides several cell adhesion pockets for cell attachment. Liver tissue engineering scaffold, extracellular matrix (ECM), were synthesized with oxidized alginate and galactosylated chitosan via Schiff base reaction. After being cultured in the scaffolds, the hepatocytes exhibited spheroidal morphology. And the multi-cellular aggregates and perfect integration were observed [90]. In addition, the formation of microcapsules is another method for liver tissue engineering. Microcapsules have the ability to encapsulate cells into microbeads. Subsequently, microbeads were covered by the semipermeable membrane to form microcapsules [91]. Microcapsules provide safety microenvironment for cells and protect the cell from interference. After encapsulated HepG2 cells into alginate-based microbeads, the proliferate and protein were clearly observed for at least 12 d [92]. These researches suggested that alginate is a potential candidate for LTE strategies.


4. Conclusion and future prospects

Alginate, as a potential biomaterial, has been successfully explored in different applications such as wound dressing, drug delivery, bone, cartilage. It could afford a moist microenvironment for wound dressing, serve as the carrier for drug delivery, and act as a scaffold for tissue engineering. The outstanding characteristic of alginate for its applications contains biocompatibility, degradable properties, gelatinization capacity, and effective modification to obtain new performances. However, alginate gel suffers from the lack of cell adhesive and mechanical properties, that cause the structural deformation of the scaffold. Despite some strategies that have been carried out to solve these problems, the disadvantages still exist such as lower mechanical properties compared with nature cartilage and lower drug delivery efficiency. For wound dressing, it lacks enough robust and flexible to allow adherence to the skin for a period of time, which maximizing patient uncomfortable and inconvenience. In the future, more novel alginate composites with controlled properties should be constructed by chemical or physical modification. That will play a vital role in intricating drug or cell-loading. Novel alginate composites also could provide mild and targeted degradation properties.



This research was supported by the Natural Science Foundation of Jiangsu Province (BK20200791). Oseweuba also gratefully acknowledges the financial support of Wallonia-Brussels International via the Wallonie-Bruxelles International (WBI) excellence Postdoctoral fellowship.


  1. 1. Smidsrød O, Skja°k-Br˦k G. Alginate as immobilization matrix for cells. Trends in Biotechnology. 1990;8:71-78
  2. 2. Kadokawa J-i, Saitou S, Shoda S-i. Preparation of alginate-polymethacrylate hybrid material by radical polymerization of cationic methacrylate monomer in the presence of sodium alginate. Carbohydrate Polymers. 2005;60(2):253-258
  3. 3. Sachan NK, Pushkar S, Jha A, Bhattcharya AJJPR. Sodium alginate: the wonder polymer for controlled drug delivery. Journal of Pharmacy Research. 2009;2(8):1191-1199
  4. 4. Sharma A, Gupta MN. Three phase partitioning of carbohydrate polymers: separation and purification of alginates. Carbohydrate Polymers. 2002;48(4):391-395
  5. 5. Yang J-S, Xie Y-J, He W. Research progress on chemical modification of alginate: A review. Carbohydrate Polymers. 2011;84(1):33-39
  6. 6. Rhein-Knudsen N, Ale MT, Ajalloueian F, Meyer AS. Characterization of alginates from Ghanaian brown seaweeds: Sargassum spp. and Padina spp. Food Hydrocolloids. 2017;71:236-244
  7. 7. Otterlei M, Østgaard K, Skjåk-Bræk G, Smidsrød O, Soon-Shiong P, Espevik T. Induction of Cytokine Production from Human Monocytes Stimulated with Alginate. Journal of Immunotherapy. 1991;10(4):286-291
  8. 8. Johnson FA, Craig DQM, Mercer AD. Characterization of the Block Structure and Molecular Weight of Sodium Alginates. Journal of Pharmacy and Pharmacology. 1997;49(7):639-643
  9. 9. Fu S, Thacker A, Sperger DM, Boni RL, Buckner IS, Velankar S, et al. Relevance of Rheological Properties of Sodium Alginate in Solution to Calcium Alginate Gel Properties. AAPS PharmSciTech. 2011;12(2):453-460
  10. 10. D’Ayala GG, Malinconico M, Laurienzo P. Marine Derived Polysaccharides for Biomedical Applications: Chemical Modification Approaches. Molecules. 2008;13(9):2069-2106
  11. 11. Shimokawa T, Yoshida S, Takeuchi T, Murata K, Ishii T, Kusakabe I. Preparation of Two Series of Oligo-guluronic Acids from Sodium Alginate by Acid Hydrolysis and Enzymatic Degradation. Bioscience, Biotechnology, and Biochemistry. 1996;60(9):1532-1534
  12. 12. Rinaudo MJPB. On the abnormal exponents a ν and a D in Mark Houwink type equations for wormlike chain polysaccharides. Polymer Bulletin. 1992;27(5):585-589
  13. 13. LeRoux MA, Guilak F, Setton LA. Compressive and shear properties of alginate gel: Effects of sodium ions and alginate concentration. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 1999;47(1):46-53
  14. 14. Larsen BE, Bjørnstad J, Pettersen EO, Tønnesen HH, Melvik JE. Rheological characterization of an injectable alginate gel system. BMC Biotechnology. 2015;15(1):29
  15. 15. Jiménez-Escrig A, Sánchez-Muniz FJ. Dietary fibre from edible seaweeds: Chemical structure, physicochemical properties and effects on cholesterol metabolism. Nutrition Research. 2000;20(4):585-598
  16. 16. Tam SK, Dusseault J, Bilodeau S, Langlois G, Hallé J-P, Yahia LH. Factors influencing alginate gel biocompatibility. Journal of Biomedical Materials Research, Part A. 2011;98A(1):40-52
  17. 17. Zimmermann U, Klöck G, Federlin K, Hannig K, Kowalski M, Bretzel RG, et al. Production of mitogen-contamination free alginates with variable ratios of mannuronic acid to guluronic acid by free flow electrophoresis. Electrophoresis. 1992;13(5):269-274
  18. 18. de Vos P, Faas MM, Strand B, Calafiore R. Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials. 2006;27(32):5603-5617
  19. 19. Park H, Park KJPr. Biocompatibility issues of implantable drug delivery systems. Pharmaceutical Research. 1996;13(12):1770-1776
  20. 20. Tibbitt MW, Anseth KS. Dynamic Microenvironments: The Fourth Dimension. 2012;4(160):160ps24-ps24
  21. 21. Lueckgen A, Garske DS, Ellinghaus A, Desai RM, Stafford AG, Mooney DJ, et al. Hydrolytically-degradable click-crosslinked alginate hydrogels. Biomaterials. 2018;181:189-198
  22. 22. Sun J, Tan H. Alginate-Based Biomaterials for Regenerative Medicine Applications. Materials. 2013;6(4):1285-1309
  23. 23. Hunt NC, Smith AM, Gbureck U, Shelton RM, Grover LM. Encapsulation of fibroblasts causes accelerated alginate hydrogel degradation. Acta Biomaterialia. 2010;6(9):3649-3656
  24. 24. Al-Shamkhani A, Duncan R. Radioiodination of Alginate via Covalently-Bound Tyrosinamide Allows Monitoring of its Fate In Vivo. Journal of Bioactive and Compatible Polymers. 1995;10(1):4-13
  25. 25. Hoque J, Haldar J. Direct Synthesis of Dextran-Based Antibacterial Hydrogels for Extended Release of Biocides and Eradication of Topical Biofilms. ACS Applied Materials & Interfaces. 2017;9(19):15975-15985
  26. 26. Guest JF, Ayoub N, McIlwraith T, Uchegbu I, Gerrish A, Weidlich D, et al. Health economic burden that different wound types impose on the UK's National Health Service. International wound journal. 2017;14(2):322-330
  27. 27. Boateng JS, Matthews KH, Stevens HNE, Eccleston GM. Wound Healing Dressings and Drug Delivery Systems: A Review. Journal of Pharmaceutical Sciences. 2008;97(8):2892-2923
  28. 28. Aderibigbe BA, Buyana B. Alginate in Wound Dressings. Pharmaceutics. 2018;10(2):42
  29. 29. Jayakumar R, Prabaharan M, Sudheesh Kumar PT, Nair SV, Tamura H. Biomaterials based on chitin and chitosan in wound dressing applications. Biotechnology Advances. 2011;29(3):322-337
  30. 30. Queen D, Orsted H, Sanada H, Sussman G. A dressing history. International Wound Journal. 2004;1(1):59-77
  31. 31. Li Y, Han Y, Wang X, Peng J, Xu Y, Chang J. Multifunctional Hydrogels Prepared by Dual Ion Cross-Linking for Chronic Wound Healing. ACS Applied Materials & Interfaces. 2017;9(19):16054-16062
  32. 32. Thomas A, Harding KG, Moore K. Alginates from wound dressings activate human macrophages to secrete tumour necrosis factor-α. Biomaterials. 2000;21(17):1797-1802
  33. 33. Wang T, Zhang F, Zhao R, Wang C, Hu K, Sun Y, et al. Polyvinyl Alcohol/Sodium Alginate Hydrogels Incorporated with Silver Nanoclusters via Green Tea Extract for Antibacterial Applications. Designed Monomers and Polymers. 2020;23(1):118-133
  34. 34. Topuz F, Henke A, Richtering W, Groll J. Magnesium ions and alginate do form hydrogels: a rheological study. Soft Matter. 2012;8(18):4877-4881
  35. 35. Dong Y, Dong W, Cao Y, Han Z, Ding Z. Preparation and catalytic activity of Fe alginate gel beads for oxidative degradation of azo dyes under visible light irradiation. Catalysis Today. 2011;175(1):346-355
  36. 36. Karri VVSR, Kuppusamy G, Talluri SV, Mannemala SS, Kollipara R, Wadhwani AD, et al. Curcumin loaded chitosan nanoparticles impregnated into collagen-alginate scaffolds for diabetic wound healing. International Journal of Biological Macromolecules. 2016;93:1519-1529
  37. 37. Orlowska J, Kurczewska U, Derwinska K, Orlowski W, Orszulak-Michalak D. In vitro evaluation of immunogenic properties of active dressings %J Current Issues in Pharmacy and Medical Sciences. 2014;27(1):55-60
  38. 38. Sudheesh Kumar PT, Raj NM, Praveen G, Chennazhi KP, Nair SV, Jayakumar R. In vitro and in vivo evaluation of microporous chitosan hydrogel/nanofibrin composite bandage for skin tissue regeneration. Tissue engineering Part A. 2013;19(3-4):380-392
  39. 39. Mndlovu H, du Toit LC, Kumar P, Marimuthu T, Kondiah PPD, Choonara YE, et al. Development of a fluid-absorptive alginate-chitosan bioplatform for potential application as a wound dressing. Carbohydrate Polymers. 2019;222:114988
  40. 40. Zhao W-Y, Fang Q-Q , Wang X-F, Wang X-W, Zhang T, Shi B-H, et al. Chitosan-calcium alginate dressing promotes wound healing: A preliminary study. Wound Repair and Regeneration. 2020;28(3):326-337
  41. 41. Tarun K, Gobi N. Calcium alginate/PVA blended nano fibre matrix for wound dressing. Indian Journal of Fibre & Textile Research. 2012, 37:127-132
  42. 42. Demling RH, Leslie DeSanti MD. The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. Burns. 2002;28(3):264-266
  43. 43. Chen K, Wang F, Liu S, Wu X, Xu L, Zhang D. In situ reduction of silver nanoparticles by sodium alginate to obtain silver-loaded composite wound dressing with enhanced mechanical and antimicrobial property. International Journal of Biological Macromolecules. 2020;148:501-509
  44. 44. Bradford C, Freeman R, Percival SL. In vitro study of sustained antimicrobial activity of a new silver alginate dressing. The journal of the American College of Certified Wound Specialists. 2009;1(4):117-120
  45. 45. Wiegand C, Heinze T, Hipler UC. Comparative in vitro study on cytotoxicity, antimicrobial activity, and binding capacity for pathophysiological factors in chronic wounds of alginate and silver-containing alginate. Wound Repair and Regeneration. 2009;17(4):511-521
  46. 46. Boontheekul T, Kong H-J, Mooney DJ. Controlling alginate gel degradation utilizing partial oxidation and bimodal molecular weight distribution. Biomaterials. 2005;26(15):2455-2465
  47. 47. He S, Zhong S, Xu L, Dou Y, Li Z, Qiao F, et al. Sonochemical fabrication of magnetic reduction-responsive alginate-based microcapsules for drug delivery. International Journal of Biological Macromolecules. 2020;155:42-49
  48. 48. Lengert E, Saveleva M, Verkhovskii R, Abramova A, Goryacheva IJML. Novel formulation of glucocorticoid based on silver alginate microcapsules for intraarticular drug delivery. Materials Letters. 2021;288:129339
  49. 49. Kurczewska J, Pecyna P, Ratajczak M, Gajęcka M, Schroeder G. Halloysite nanotubes as carriers of vancomycin in alginate-based wound dressing. Saudi Pharmaceutical Journal. 2017;25(6):911-920
  50. 50. Lin N, Gèze A, Wouessidjewe D, Huang J, Dufresne A. Biocompatible Double-Membrane Hydrogels from Cationic Cellulose Nanocrystals and Anionic Alginate as Complexing Drugs Codelivery. ACS Applied Materials & Interfaces. 2016;8(11):6880-6889
  51. 51. Zhong D, Liu Z, Xie S, Zhang W, Zhang Y, Xue W. Study on poly(D,L-lactic) microspheres embedded in calcium alginate hydrogel beads as dual drug delivery systems. Journal of Applied Polymer Science. 2013;129(2):767-772
  52. 52. Rezk AI, Obiweluozor FO, Choukrani G, Park CH, Kim CS. Drug release and kinetic models of anticancer drug (BTZ) from a pH-responsive alginate polydopamine hydrogel: Towards cancer chemotherapy. International Journal of Biological Macromolecules. 2019;141:388-400
  53. 53. Manatunga DC, de Silva RM, de Silva KMN, de Silva N, Bhandari S, Yap YK, et al. pH responsive controlled release of anti-cancer hydrophobic drugs from sodium alginate and hydroxyapatite bi-coated iron oxide nanoparticles. European Journal of Pharmaceutics and Biopharmaceutics. 2017;117:29-38
  54. 54. Anitha A, Deepagan VG, Divya Rani VV, Menon D, Nair SV, Jayakumar R. Preparation, characterization, in vitro drug release and biological studies of curcumin loaded dextran sulphate–chitosan nanoparticles. Carbohydrate Polymers. 2011;84(3):1158-1164
  55. 55. Silva EA, Mooney DJ. Effects of VEGF temporal and spatial presentation on angiogenesis. Biomaterials. 2010;31(6):1235-1241
  56. 56. Ji L, Zhang F, Zhu L, Jiang J. An in-situ fabrication of bamboo bacterial cellulose/sodium alginate nanocomposite hydrogels as carrier materials for controlled protein drug delivery. International Journal of Biological Macromolecules. 2021;170:459-468
  57. 57. Griffith LG, Naughton G. Tissue Engineering--Current Challenges and Expanding Opportunities. Science. 2002;295(5557):1009-1014
  58. 58. Li Z, Du T, Ruan C, Niu X. Bioinspired mineralized collagen scaffolds for bone tissue engineering. Bioactive Materials. 2021;6(5):1491-1511
  59. 59. Nie X, Chuah YJ, Zhu W, He P, Peck Y, Wang D-A. Decellularized tissue engineered hyaline cartilage graft for articular cartilage repair. Biomaterials. 2020;235:119821
  60. 60. Zhu J, Chen D, Du J, Chen X, Wang J, Zhang H, et al. Mechanical matching nanofibrous vascular scaffold with effective anticoagulation for vascular tissue engineering. Composites Part B: Engineering. 2020;186:107788
  61. 61. Sharifi S, Islam MM, Sharifi H, Islam R, Koza D, Reyes-Ortega F, et al. Tuning gelatin-based hydrogel towards bioadhesive ocular tissue engineering applications. Bioactive Materials. 2021;6(11):3947-3961
  62. 62. Yang W, Xu H, Lan Y, Zhu Q , Liu Y, Huang S, et al. Preparation and characterisation of a novel silk fibroin/hyaluronic acid/sodium alginate scaffold for skin repair. International Journal of Biological Macromolecules. 2019;130:58-67
  63. 63. Rocca DGD, Willenberg BJ, Qi Y, Simmons CS, Rubiano A, Ferreira LF, et al. An injectable capillary-like microstructured alginate hydrogel improves left ventricular function after myocardial infarction in rats. International Journal of Cardiology. 2016;220:149-154
  64. 64. Venkatesan J, Bhatnagar I, Manivasagan P, Kang K-H, Kim S-K. Alginate composites for bone tissue engineering: A review. International Journal of Biological Macromolecules. 2015;72:269-281
  65. 65. Sowjanya JA, Singh J, Mohita T, Sarvanan S, Moorthi A, Srinivasan N, et al. Biocomposite scaffolds containing chitosan/alginate/nano-silica for bone tissue engineering. Colloids and Surfaces B: Biointerfaces. 2013;109:294-300
  66. 66. Venkatesan J, Nithya R, Sudha PN, Kim S-K. Chapter Four - Role of Alginate in Bone Tissue Engineering. In: Kim S-K, editor. Advances in Food and Nutrition Research. 73: Academic Press; 2014. p. 45-57
  67. 67. Giri T, Thakur D, Alexander A, Ajazuddin, Badwaik H, Tripathi DK. Alginate based hydrogel as a potential biopolymeric carrier for drug delivery and cell delivery systems: present status and applications. Current Drug Delivery. 2012;9:539-555
  68. 68. Florczyk SJ, Kim D-J, Wood DL, Zhang M. Influence of processing parameters on pore structure of 3D porous chitosan–alginate polyelectrolyte complex scaffolds. Journal of Biomedical Materials Research. Part A. 2011;98A(4):614-620
  69. 69. Florczyk SJ, Leung M, Li Z, Huang JI, Hopper RA, Zhang M. Evaluation of three-dimensional porous chitosan–alginate scaffolds in rat calvarial defects for bone regeneration applications. Journal of Biomedical Materials Research, Part A. 2013;101(10):2974-2983
  70. 70. Li Z, Ramay HR, Hauch KD, Xiao D, Zhang M. Chitosan–alginate hybrid scaffolds for bone tissue engineering. Biomaterials. 2005;26(18):3919-3928
  71. 71. Grinnell F. Fibroblast biology in three-dimensional collagen matrices. Trends in Cell Biology. 2003;13(5):264-269
  72. 72. García AJ. Get a grip: integrins in cell–biomaterial interactions. Biomaterials. 2005;26(36):7525-7529
  73. 73. Sotome S, Uemura T, Kikuchi M, Chen J, Itoh S, Tanaka J, et al. Synthesis and in vivo evaluation of a novel hydroxyapatite/collagen–alginate as a bone filler and a drug delivery carrier of bone morphogenetic protein. Materials Science and Engineering: C. 2004;24(3):341-347
  74. 74. Sharma C, Dinda AK, Potdar PD, Chou C-F, Mishra NC. Fabrication and characterization of novel nano-biocomposite scaffold of chitosan–gelatin–alginate–hydroxyapatite for bone tissue engineering. Materials Science and Engineering: C. 2016;64:416-427
  75. 75. Lin H-R, Yeh Y-J. Porous alginate/hydroxyapatite composite scaffolds for bone tissue engineering: Preparation, characterization, and in vitro studies. Journal of Biomedical Materials Research, Part B. 2004;71B(1):52-65
  76. 76. Kim H-L, Jung G-Y, Yoon J-H, Han J-S, Park Y-J, Kim D-G, et al. Preparation and characterization of nano-sized hydroxyapatite/alginate/chitosan composite scaffolds for bone tissue engineering. Materials Science and Engineering: C. 2015;54:20-25
  77. 77. Petrović M, Čolović B, Jokanović V, Marković DJJoCPR. Self assembly of biomimetic hydroxyapatite on the surface of different polymer thin films. Journal of Ceramic Processing Research. 2012;13(4):398-404
  78. 78. Firouzi N, Baradar Khoshfetrat A, Kazemi D. Enzymatically gellable gelatin improves nano-hydroxyapatite-alginate microcapsule characteristics for modular bone tissue formation. Journal of Biomedical Materials Research, Part A. 2020;108(2):340-350
  79. 79. Armiento AR, Stoddart MJ, Alini M, Eglin D. Biomaterials for articular cartilage tissue engineering: Learning from biology. Acta Biomaterialia. 2018;65:1-20
  80. 80. Sahoo DR, Biswal T. Alginate and its application to tissue engineering. SN Applied Sciences. 2021;3(1):30
  81. 81. Bouhadir KH, Lee KY, Alsberg E, Damm KL, Anderson KW, Mooney DJJBp. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnology Progress. 2001;17(5):945-950
  82. 82. Erickson AE, Sun J, Lan Levengood SK, Swanson S, Chang F-C, Tsao CT, et al. Chitosan-based composite bilayer scaffold as an in vitro osteochondral defect regeneration model. Biomedical Microdevices. 2019;21(2):34
  83. 83. Mahapatra C, Jin G-Z, Kim H-W. Alginate-hyaluronic acid-collagen composite hydrogel favorable for the culture of chondrocytes and their phenotype maintenance. Tissue Engineering and Regenerative Medicine. 2016;13(5):538-546
  84. 84. Darnell MC, Sun J-Y, Mehta M, Johnson C, Arany PR, Suo Z, et al. Performance and biocompatibility of extremely tough alginate/polyacrylamide hydrogels. Biomaterials. 2013;34(33):8042-8048
  85. 85. Liao I-C, Moutos FT, Estes BT, Zhao X, Guilak F. Composite Three-Dimensional Woven Scaffolds with Interpenetrating Network Hydrogels to Create Functional Synthetic Articular Cartilage. Advanced Functional Materials. 2013;23(47):5833-5839
  86. 86. Arjmandi M, Ramezani M. Mechanical and tribological assessment of silica nanoparticle-alginate-polyacrylamide nanocomposite hydrogels as a cartilage replacement. Journal of the Mechanical Behavior of Biomedical Materials. 2019;95:196-204
  87. 87. Saygili E, Kaya E, Ilhan-Ayisigi E, Saglam-Metiner P, Alarcin E, Kazan A, et al. An alginate-poly(acrylamide) hydrogel with TGF-β3 loaded nanoparticles for cartilage repair: Biodegradability, biocompatibility and protein adsorption. International Journal of Biological Macromolecules. 2021;172:381-393
  88. 88. Asrani SK, Devarbhavi H, Eaton J, Kamath PS. Burden of liver diseases in the world. Journal of Hepatology. 2019;70(1):151-171
  89. 89. Rajalekshmi R, Kaladevi Shaji A, Joseph R, Bhatt A. Scaffold for liver tissue engineering: Exploring the potential of fibrin incorporated alginate dialdehyde–gelatin hydrogel. International Journal of Biological Macromolecules. 2021;166:999-1008
  90. 90. Chen F, Tian M, Zhang D, Wang J, Wang Q , Yu X, et al. Preparation and characterization of oxidized alginate covalently cross-linked galactosylated chitosan scaffold for liver tissue engineering. Materials Science and Engineering: C. 2012;32(2):310-320
  91. 91. Majewski RL, Zhang W, Ma X, Cui Z, Ren W, Markel DCJJoab, et al. Bioencapsulation technologies in tissue engineering. Journal of Applied Biomaterials & Functional Materials. 2016;14(4):395-403
  92. 92. Haque T, Chen H, Ouyang W, Martoni C, Lawuyi B, Urbanska AM, et al. In vitro study of alginate–chitosan microcapsules: an alternative to liver cell transplants for the treatment of liver failure. Biotechnology Letters. 2005;27(5):317-322

Written By

Yaling Deng, Ningning Yang, Oseweuba Valentine Okoro, Amin Shavandi and Lei Nie

Submitted: July 15th, 2021 Reviewed: July 16th, 2021 Published: August 12th, 2021